August 2026 in “Frontiers in Veterinary Science” This review article analyzes the differences and challenges in managing nonscarring alopecia across humans and companion animals like dogs and cats, highlighting the importance of species-specific clinical trials and treatment formulations due to differences in hair and skin characteristics.
June 2026 in “International Journal of Ayurvedic Medicine” The study found that Asthimajjapachak Churna led to greater improvement in managing hair fall among young females compared to Shwadamshtradi Rasayana Churna, particularly through alleviation of Asthigata dosha.
June 2026 in “Preprints.org” This study examined the current clinical practices for diagnosing and managing alopecia areata in Poland, finding that patient care is inadequate and falls short in using validated severity tools and providing access to advanced therapies despite the availability of new medications like Janus kinase inhibitors.
June 2026 in “Actas Dermo-Sifiliográficas” This review reports that spironolactone and metformin show promise in managing adult female acne, but calls for more robust studies to better assess their efficacy and safety.
This review examines the potential of Parquetina nigrescens for managing Polyendocrine Metabolic Ovarian Syndrome, emphasizing its pharmacological activities and highlighting its promise as an affordable complementary therapy.
June 2026 in “Health Nanotechnology” This narrative review suggests that nanoformulated phytochemicals hold promise for managing polycystic ovarian syndrome, but their efficacy and safety compared to standard treatments require further validation through clinical studies.
May 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This review article examines recent advances in understanding and managing various types of alopecia, highlighting modern therapeutic strategies such as individualized treatment plans, combination therapies, and regenerative approaches aimed at improving hair regrowth and minimizing adverse effects.
May 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This study assesses the effectiveness of polyherbal formulations in managing hair issues such as dandruff, dryness, premature greying, baldness, and excessive hair fall, in response to increasing hair loss among younger individuals due to stress, poor diet, and chemical use.
May 2026 in “IOSR Journal of Dental and Medical Sciences” This study evaluated the use of automated microneedling therapy for managing facial scars, finding significant improvement in scar size and vascularity with minimal complications, particularly between the second and third treatment sessions, and achieving good to excellent patient satisfaction in two-thirds of participants.
April 2026 in “International Journal of Research and Review” This article reviews current literature and suggests that managing gout with early urate-lowering therapy, within a 'treat-to-target' strategy, can help prevent systemic complications and address the rising prevalence of hyperuricemia-related diseases.
April 2026 in “International Journal of Pharmacy and Pharmaceutical Science” This review reported that rosemary shows promise in managing ischemic stroke and other oxidative stress-related conditions due to its anti-inflammatory and antioxidant properties, highlighting its potential neuroprotective benefits for cognitive and brain health.
March 2026 in “Balkan Sağlık Bilimleri Dergisi” This review discusses the role of nurse navigators in managing polycystic ovary syndrome, highlighting their support in symptom management, lifestyle changes, psychosocial care, and evidence-based practices, but presents no new findings.
February 2026 in “International Journal on Science and Technology” This review discusses the potential benefits of Vitex negundo for managing polycystic ovarian disease, highlighting its promising effects in animal models, but notes that more rigorous human trials are needed to confirm these findings.
January 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This study evaluated a novel Dual-Phase Herbal Elixir aimed at managing hair fall and dandruff, finding that its unique oil and aqueous layers significantly reduced scalp flakiness and hair fall in a six-week trial, underscoring its potential as a natural hair care alternative.
January 2026 in “Dermatologic Therapy” This review indicates that while microneedling shows potential for managing androgenetic alopecia, particularly in combination with other treatments, the existing evidence is of low to moderate quality, and more robust trials are needed to confirm its clinical efficacy and safety.
January 2026 in “Journal of advanced Biomedical and Pharmaceutical Sciences” This review highlights niosomal cetirizine as a promising strategy for managing alopecia, potentially enhancing local bioavailability and reducing systemic exposure.
January 2026 in “International Journal of Applied Research” This review examines the potential role of homoeopathy in managing autoimmune diseases, focusing on evidence from recent case reports and studies. It discusses clinical outcomes in various conditions and explores possible immunomodulatory mechanisms associated with homoeopathic interventions.
December 2025 in “Editora Pasteur eBooks” A combined medical and aesthetic approach is crucial for effectively managing PCOS and its skin-related issues.
December 2025 in “Zenodo (CERN European Organization for Nuclear Research)” This review reports that anti-androgens, often combined with contraception, are supported for managing PCOS symptoms related to high androgen levels, but uncertainties remain about long-term safety and metabolic effects, indicating a need for future research on various treatment approaches.
December 2025 in “Zenodo (CERN European Organization for Nuclear Research)” This review addresses the use of anti-androgens in managing symptoms of polycystic ovary syndrome, noting both their clinical effectiveness and associated safety concerns, while highlighting the need for more research into their long-term safety and metabolic effects.
November 2025 in “Clinical Endocrinology” This analysis reports no significant differences between spironolactone and metformin for managing PCOS, noting spironolactone remains a potential off-label option for patients unable to use hormonal contraceptives, but larger studies are necessary to confirm its efficacy.
October 2025 in “Clinical Cosmetic and Investigational Dermatology” This study established consensus guidelines for diagnosing and managing androgenetic alopecia in Egypt, emphasizing individualized care and emerging therapies based on a survey of Egyptian dermatologists and refinement through expert review.
September 2025 in “Journal of Cutaneous Medicine and Surgery” This expert panel review developed consensus recommendations for managing androgenetic alopecia in Canadian adults, endorsing seven interventions like oral and topical medications and platelet-rich plasma.
September 2025 in “Consilium Medicum” This study discusses the role of 5α-reductase inhibitors in managing lower urinary tract symptoms caused by benign prostatic hyperplasia and suggests their potential use in other conditions like prostate cancer chemoprevention and androgenetic alopecia treatment, emphasizing appropriate dosing to reduce surgical complications.
In this case study, individualized homeopathic treatment resulted in complete hair regrowth with no recurrence in a patient with Alopecia Areata, highlighting the potential of homeopathy for managing autoimmune hair loss effectively.
This review consolidates the opinions of top Canadian dermatologists on managing telogen effluvium, highlighting the importance of proper diagnosis, identifying triggers, and patient education.
July 2025 in “Russian Journal of Transplantology and Artificial Organs” This research highlights advancements in reconstructive surgery for managing scars, emphasizing the importance of combined surgical and nonsurgical interventions like platelet-rich plasma and stem cell therapy to prevent and treat thick scar tissue while enhancing functionality and aesthetic outcomes.
July 2025 in “JAAD Case Reports” A thorough assessment and combined treatment are crucial for managing complex alopecia, especially in patients with skin of color.
July 2025 in “Journal of Pharmacognosy and Phytochemistry” This review explores the potential benefits of plant-based diets, herbal remedies, and phytochemicals for managing PCOS, suggesting they may help regulate menstrual cycles, improve metabolic parameters, and reduce androgen levels, offering a promising, holistic approach to treatment.
July 2025 in “Future Journal of Pharmaceuticals and Health Sciences” This study developed a polyherbal chocolate formulation aimed at managing PCOS and hormonal balance, finding that formulation F2 showed excellent organoleptic properties and stability, with future in vivo studies being suggested.